Gesamtlänge aller Episoden: 3 days 11 hours 18 minutes
Today’s episode features Amanda Feilding, Countess of Wemyss and March, founder of the Beckley Foundation, which directs and supports research into psychoactive substances and their effect on the brain and cognitive function.
This week’s episode features Carl Hart, professor of neuroscience and psychology at Columbia University in New York. Professor Nutt and Professor Hart discuss drug addiction and its political context in the US. Are drug policies racist? Were they made to
Psilocybin is being heralded as a major breakthrough in the fight against depression, but how does it compare to the most effective treatment that doctors prescribe for depression? Find out, on the Drug Science Podcast with Dr Robin Carhart-Harris.
This week’s episode features Dr Gabor Maté, a Hungarian-Canadian physician who’s main interests include childhood development and trauma, and their impact on lifelong physical and mental health.
The UK has failed to adopt the evidence-based drug intervention known as ‘Drug Consumption Rooms’. Activist Peter Krykant has decided to take matters into his own hands and has set up the very first UK drug consumption room.
How the philosophy of psychedelics has shaped philosophers’ perceptions of consciousness and reality.
In this week’s episode Professor David Nutt is joined by Dr David Luke to discuss: yoga, meditation, holotropic breathwork, sensory deprivation, hypnosis, anechoic chambers, religious experiences, carbogen inhalation therapy, and telepathy.
“When at war, all reason is treason”. The ‘war on drugs’ is happening in every country in the world, however, each jurisdiction has it’s own set of rules and protocols for addressing this issue.
On the evening of 2 January 2017 near Huddersfield, Yassar Yaqub was a passenger in a car stopped by police on the M62 motorway and was fatally shot by a West Yorkshire Police firearms officer…but why?
Psychedelics have transcended from counter-culture to the mainstream. Dr. David Nichols has been at the forefront of pharmacology and chemistry throughout this transition and has been shifting this paradigm since 1969.